Publications


2022

  1. Todd JL, Neely ML, Overton R, Mulder H, Roman J, Lasky JA, de Andrade JA, Gulati M, Huang H, Leonard TB, Hesslinger C, Noth I, Belperio JA, Flaherty KR, Palmer SM; Association of Circulating Proteins with Disease Specific Measures in the Multicenter IPF-PRO Registry Cohort Lung. 2022 Jan 23

  2. Todd JL, Neely ML, Overton R, Mulder H, Roman J, Lasky JA, de Andrade JA, Gulati M, Huang H, Leonard TB, Hesslinger C, Noth I, Belperio JA, Flaherty KR, Palmer SM; Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort. Lung 200, 11–18, Feb 2022


2021

  1. Giarraputo J, Giamberardino S, Arvai S, Maichle S, Eckstein C, Newby LK, Gregory S. Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis. J Neuroimmunol. 2021 Mar 5;354:577541


2020

  1. Douglas TD, Newby LK, Eckstrand J, Wixted D, Singh RH. Lipid changes in the metabolome of a single case study with maple syrup urine disease (MSUD) after five days of improved diet adherence of controlled branched-chain amino acids (BCAA). Citation: Mol Genet Metab Rep. 2020 Oct 14;25:100651

  2. Nordeck, C., Gryczynski, J., O’Grady, K., Polak, K., Svikis, D., McNeely, J., Wu, L.T., Schwartz, R. Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients. Citation: Drug Alcohol Depend. 2020 Apr 1; 209:107939

  3. Penning, ML; Blach, C; Walden, A; Wang, P; Donovan, KM; Garza, MY; Wang, Z; Frund, J; Syed, S; Syed, M; Del Fiol, G; Newby, LK; Pieper, C; Zozus, M. Near Real Time EHR Data Utilization in a Clinical Study. Citation: Stud Health Technol Inform. 2020 Jun 16;270:337-341

  4. Todd, JL; Vinisko, R; Liu, Y; Neely, ML; Overton, R; Flaherty, KR; Noth, I; Newby, LK; Lasky, JA; Olman, MA; Hesslinger, C; Leonard, TB; Palmer, SM; Belperio, JA; & IPF-PRO Registry investigators.  Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort. Citation: BMC pulmonary medicine, 20(1), 64

  5. Walden A, Garvin L, Smerek M, Johnson C. User-centered design principles in the development of clinical research tools. Citation: Clin Trials. 2020 Dec;17(6):703-7112019


2019

  1. Harskamp RE, Granger TM, Clare RM, White KR, Lopes RD, Pieper KS, Granger CB, Newgard CB, Shah SH, Newby LK. Peripheral blood metabolite profiles associated with new onset atrial fibrillation. Citation: Am Heart J. 2019 Feb 14;211:54-59.

  2. Wu, L-T, Payne, EH, Roseman, K, Kingsbury, C, Case, A, Nelson, C and Lindblad, R. Clinical workflow and substance use screening, brief intervention, and referral to treatment data in the electronic health records: A National Drug Abuse Treatment Clinical Trials Network study. Citation: eGEMs (Generating Evidence & Methods to improve patient outcomes), 7(1): 35, pp. 1–15.

  3. Beskow LM, Brelsford KM, Hammack CM. Patient perspectives on use of electronic health records for research recruitment. Citation: BMC Medical Research Methodology, vol. 19, no. 1, 2019.

  4. Todd JL, Neely ML, Overton R, Durham K, Gulati M, Huang H, Roman J, Newby LK, Flaherty KR, Vinisko R, Liu Y, Roy J, Schmid R, Strobel B, Hesslinger C, Leonard TB, Noth I, Belperio JA, Palmer SM. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry. Citation: Respir Res 20, 227 (2019).

  5. Rasouly HM, Groopman EE, Heyman-Kantor R, Fasel DA, Mitrotti A, Westland R, Bier L, Weng C, Ren Z, Copeland B, Krithivasan P, Chung WK, Sanna-Cherchi S, Goldstein DB, Gharavi AG. The Burden of Candidate Pathogenic Variants for Kidney and Genitourinary Disorders Emerging From Exome Sequencing. Citation: Ann Intern Med. (January 2019) 170:11-21. doi:10.7326/M18 1241.

  6. Andersen SL, Briggs FBS, Winnike JH, Natanzon Y, Maichle S, Knagge KJ, Newby LK, Gregory SG. Metabolome-based signature of disease pathology in MS. Citation: Multiple Sclerosis and Related Disorders (March 2019)

  7. Adam, A, Schwartz RP, Wu LT, Subramaniam G, Laska E, Sharma G, Mili S, McNeely J. Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool. Citation: Addict Sci Clin Pract. 2019; 14: 39.

  8. John, W.S., Grover, K., Greenblatt, L.H., Schwartz, R.P., Wu, L.-T. E-Cigarette Use Among Adult Primary Care Patients: Results from a Multisite Study. Citation: J Gen Intern Med. 2019 Nov 8


2018

  1. Brelsford KM, Spratt SE, Beskow LM. Research use of electronic health records: patients’ perspectives on contact by researchers. Citation: J Am Med Inform Assoc. 2018 Sep 1;25(9):1122-1129.

  2. Noppert GA, Brown CS, Chanti-Ketterl M, Hall KS, Newby LK, Cohen HJ, Morey MC. The Impact of Multiple Dimensions of Socioeconomic Status on Physical Functioning Across the Life Course, Gerontology and Geriatric Medicine (Aug 2018) 4:2333721418794021. eCollection 2018 Jan-Dec. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113730/

  3. John WS, Zhu H, Mannelli P, Schwartz RP, Subramaniam GA, Wu LT. Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients. Citation: Drug Alcohol Depend. 2018 Jun 1;187:79-87.

  4. Parker D, Sloane R, Pieper CF, Hall KS, Kraus VB, Kraus WE, Huebner JL, Ilkayeva OR, Bain JR, Newby LK, Cohen HJ, Morey MC. Age-Related Adverse Inflammatory and Metabolic Changes Begin Early in Adulthood, The Journals of Gerontology: Series A, gly121, (May 2018)  https://doi.org/10.1093/gerona/gly121


2017

  1. Schiller HB, Mayr CH, Leuschner G, Strunz M, Staab-Weijnitz C, Preisendörfer S, Eckes B, Moinzadeh P, Krieg T, Schwartz DA, Hatz RA, Behr J, Mann M, Eickelberg O. Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis. Citation: Am J Respir Crit Care Med. 2017 Nov 15;196(10):1298-1310.

  2. Galarza-Munoz G, Briggs FBS, Evsyukova I, Kennedy EM, Nyanhete T, Wang L, Gregory SG, Garcia-Blanco MA. Human epistatic interaction controls IL7R splicing and increases multiple sclerosis risk. Cell 2017;169:72-84.e13. PMCID: PMC5456452

  3. Hall, KS, Cohen, HJ, Pieper, CF, Fillenbaum, GG, Kraus, WE, Huffman, KM, Cornish, MA, Shiloh, A, Flynn, C, Sloane, R, Newby, LK, and Morey, MC. “Physical Performance Across the Adult Life Span: Correlates With Age and Physical Activity.” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 72, no. 4 (April 2017): 572-578.


2016

  1. Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus M. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform 2016, available online 10/29/2016.

  2. Inoue M, Chen P, Siecinski S, Li Q, Steinman L, Gregory SG, Benner E, Shinohara ML. An interferon-B-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage. Nat Neurosci 2016 Nov 7. doi: 10.1038/nn.4421. 

  3. Hall, KS, Cohen, HJ, Pieper, CF, Fillenbaum, GG, Kraus, WE, Huffman, KM, Cornish, MA, Shiloh, A, Flynn, C, Sloane, R, Newby, LK, and Morey, MC. “Physical Performance Across the Adult Life Span: Correlates With Age and Physical Activity.” The journals of gerontology. Series A, Biological sciences and medical sciences (June 29, 2016). PMID   27356977

  4. Wu LT. Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug and Alcohol Dependence. Available online 19 October 2016. http://www.sciencedirect.com/science/article/pii/S0376871616309504

  5. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Corrigendum to “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool” [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97]. Contemp Clin Trials. 2016 Sep 22. pii: S1551-7144(16)30285-3. doi: 10.1016/j.cct.2016.09.001. PMID: 27665683.

  6. McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, Sleiter L, Russell L, Nordeck C, Sharma A, O’Grady KE, Bouk LB, Cushing C, King J, Wahle A,  Schwartz RP. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 2016 Sep 6. doi: 10.7326/M16-0317. PMID: 27595276.

  7. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Design of the NIDA clinical trials network validation study of tobacco, alcohol,  prescription medications, and substance use/misuse (TAPS) tool. Contemp Clin Trials. 2016 Sep;50:90-7. doi: 10.1016/j.cct.2016.07.013. PMID: 27444426; PMCID: PMC5035619.

  8. Zhu H, Wu LT. Trends and Correlates of Cannabis-involved Emergency Department Visits: 2004 to 2011. J Addict Med. 2016 Aug 29. PMID: 27574753.

  9. Mannelli P, Wu LT. Primary care for opioid use disorder. Subst Abuse Rehabil. 2016 Aug 16;7:107-9. doi: 10.2147/SAR.S69715. PMID: 27574479; PMCID: PMC4993411.

  10. Mannelli P, Wu LT. Family substance use screening: less to hide, more to gain. Indian J Med Res. 2016 Jun;143(6):682-684. doi: 10.4103/0971-5916.191920. PMID: 27748291.